Pharmacogenetics of Thiopurine S-Methyltransferase and Thiopurine Therapy
- 1 April 2004
- journal article
- review article
- Published by Wolters Kluwer Health in Therapeutic Drug Monitoring
- Vol. 26 (2) , 186-191
- https://doi.org/10.1097/00007691-200404000-00018
Abstract
Most medications exhibit wide interpatient variability in their efficacy and toxicity. For many medications, these interindividual differences result in part from polymorphisms in genes encoding drug-metabolizing enzymes, drug transporters, and/or drug targets (eg, receptors, enzymes). Pharmacogenomics is a burgeoning field aimed at elucidating the genetic basis of differences in drug efficacy and toxicity, using genome-wide approaches to identify the network of genes that govern an individual’s response to drug therapy. For some genetic polymorphisms, such as thiopurine S-methyltransferase (TPMT), monogenic traits have a marked effect on the pharmacokinetics of medications, such that individuals who inherit an enzyme deficiency must be treated with markedly different doses of the affected medications (eg, 5–10% of the standard thiopurine dose). This review uses the TPMT polymorphism and thiopurine therapy (eg, azathioprine, mercaptopurine) to illustrate the potential of pharmacogenomics to elucidate genetic determinants of drug response, and optimize the selection of drug therapy for individual patients.Keywords
This publication has 47 references indexed in Scilit:
- Drug methylation in cancer therapy: lessons from the TPMT polymorphismOncogene, 2003
- Case Clusters of the Severe Acute Respiratory SyndromeNew England Journal of Medicine, 2003
- Pharmacogenomics: The Inherited Basis for Interindividual Differences in Drug ResponseAnnual Review of Genomics and Human Genetics, 2001
- A map of human genome sequence variation containing 1.42 million single nucleotide polymorphismsNature, 2001
- Genetic polymorphism of thiopurine methyltransferase and its clinical relevance for childhood acute lymphoblastic leukemiaLeukemia, 2000
- Pharmacogenomics: Translating Functional Genomics into Rational TherapeuticsScience, 1999
- Hypothesis: Comparisons of inter- and intra-individual variations can substitute for twin studies in drug researchPharmacogenetics, 1998
- Molecular Diagnosis of Thiopurine S-Methyltransferase Deficiency: Genetic Basis for Azathioprine and Mercaptopurine IntoleranceAnnals of Internal Medicine, 1997
- Pharmacogenetic perspectives gained from twin and family studiesPharmacology & Therapeutics, 1989
- Pharmacogenetics of acute azathioprine toxicity: Relationship to thiopurine methyltransferase genetic polymorphismClinical Pharmacology & Therapeutics, 1989